|
Treatment for maxillary cysts |
|
Gastricel-I |
|
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
|
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
|
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) |
|
Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II |
|
Biomarkers of exposition_Uchuva Dorada |
|
Obex® - Overweight and Obese - Adults - Phase III |
|
14F7 in chronic B-cell lymphoproliferative syndrome |
|
Bioequivalence of Trienor |
|
Bioequivalence of Efavirenz |
|
Bioequivalence of Zidovudine |
|
Bioequivalence of Sildenafil |
|
Bioequivalence of Phenytoin |
|
Bioequivalence of Diltiazem retard |
|
Bioequivalence of Digoxin |
|
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
|
Bioequivalence of Clopidogrel |
|
Chitosan Unguent in burned patients |
|
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
